Funding Rounds
STipe Therapeutics

STipe Therapeutics Series A (2019, $21M)

STipe Therapeutics

Platform dedicated to harnessing the innate immune system to battle cancer.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $21.81M

Raised Date: 2019-01-01